News

Oct 2022   FamiCord Group is a network of family banking companies and 15 laboratories that together hold 50% of the cord blood banking market in Europe. In this interview we learn how FamiCord built this dominance and what trends they see for the future of biobanking and cell therapy in Europe.

Oct 2022   This story tells the experiences of a family from Japan whose son has HIE from a birth injury. They banked his younger sister's umbilical cord blood at the StemCell Institute. Thanks to the banked sibling cord blood, the family was able to travel to Duke for their son to receive cell therapy through the Duke Expanded Access program (EAP).

Sep 2022   The Cryoviva Group has cord blood laboratories in Thailand, Singapore, India, and Vietnam, and is active in banking MSC for regenerative medicine therapies. The Cryoviva Group believes that the future of the biobanking industry is to partner in providing cell therapies.

Sep 2022   ExCellThera is a biotechnology company based in Montréal that is dedicated to making cord blood transplants available to a more diverse group of patients by expanding small cord blood units so that they are big enough for therapy.

Aug 2022   Currently, 110 clinical trials with cord blood are recruiting at 281 locations. Cumulatively, 276 clinical trials performing advanced cell therapies with cord blood have been registered through the end of 2021.

Aug 2022   The United Arab Emirates has a well established and officially sanctioned infrastructure for medical tourism. Approvals for biotherapies are more readily obtained than in many western nations, leading to a booming business in regenerative medicine. At the same time, regulations around the practice of regenerative medicine follow high quality standards and are strictly enforced. New this year, the UAE is requiring that cord blood banks which operate in their country must construct a laboratory and storage facility in their country.

Jul 2022   The ReCord study is backtracking childhood leukemia to the genetic mutations present in the child's cord blood at birth. Hopefully this knowledge can be used in the future to predict which children are predisposed to childhood cancer and prevent the diagnosis.

Jul 2022   The World Stem Cell Summit, in partnership with the Regenerative Medicine Foundation, has presented their 2022 Advocacy Award to Dr. Frances Verter & the Parent’s Guide to Cord Blood Foundation. 

Jun 2022   This May, Future Health celebrated its 20th anniversary. Starting from a small biotech lab, they have grown to encompass six subsidiaries in Europe and a global reach of 94 countries. In 2022, Future Health is set to open a new biobanking storage facility in Nottingham to meet increasing demand. The new facility will include green technologies as part of the Future Health commitment to our environment and sustainability.

Jun 2022   Kinetic Stem Cell Counting is the first technology that can directly count stem cells. It is based on the unique property of stem cells, that they are capable of asymmetric self-renewal. This makes it possible to run a computer simulation of a growing culture that determines the number of stem cells present. Once validated for a specified combination of cell type and culture conditions, Kinetic Stem Cell Counting provides a stem cell count after only 3 DAYS of cell culture.